Int J Fertil Steril. 2016 Apr-Jun;10(1):79-86. doi: 10.22074/ijfs.2016.4772. Epub 2016 Apr 05.
Ethyl Pyruvate Ameliorates The Damage Induced by Cyclophosphamide on Adult Mice Testes.
International journal of fertility & sterility
Zahra Bakhtiary, Rasoul Shahrooz, Abbas Ahmadi, Farhad Soltanalinejad
Affiliations
Affiliations
- Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran.
PMID: 27123204
PMCID: PMC4845533 DOI: 10.22074/ijfs.2016.4772
Abstract
BACKGROUND: Cyclophosphamide (CP) is a chemotherapy drug which causes deleterious effects on testicular tissue and increases free radicals in the body. The aim of this study is to investigate the protective effects of ethyl pyruvate (EP) on testicular improvement in CP treated animals.
MATERIALS AND METHODS: In this experimental study, 15 male mice (6-8 weeks) were divided into 3 groups. The control group received normal saline (0.1 ml/day), intraperitoneal (IP), CP group received CP (15 mg/kg/week, IP), and the CP+EP group received EP (40 mg/kg/day, IP) plus CP. After 35 days, we assessed serum total antioxidant capacity (TAC) along with histomorphometric and histochemical analyses of the testicles.
RESULTS: The mean thickness of the germinal epithelium, diameter of seminiferous tubules, and the number of Leydig cells in the CP+EP group were higher than those of the CP group (P<0.05). The number of the mast cells in the CP+EP group significantly reduced compared with the CP group (P<0.05). Alkaline phosphatase (ALP), periodic acid-schiff (PAS) positive reactions and lipid granules in cytoplasm of the Leydig cells in the CP group increased compared with the other groups (P<0.05). TAC in the CP group significantly reduced compared with the other groups (P<0.05).
CONCLUSION: This study showed the ability of EP to reduce the destructive side effects of CP in the adult mice reproductive system.
Keywords: Cyclophosphamide; Ethyl Pyruvate; Testis
References
- Hum Pathol. 2004 Jan;35(1):34-42 - PubMed
- J Surg Res. 2009 May 15;153(2):302-9 - PubMed
- Asian J Androl. 2000 Sep;2(3):191-8 - PubMed
- J Clin Oncol. 1999 May;17(5):1493-8 - PubMed
- Asian J Androl. 2002 Sep;4(3):201-7 - PubMed
- Anim Reprod Sci. 2007 Feb;97(3-4):303-13 - PubMed
- J Pharmacol Exp Ther. 1970 Aug;174(2):206-10 - PubMed
- J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S486-94 - PubMed
- Curr Pharm Des. 1999 Aug;5(8):627-43 - PubMed
- Drug Chem Toxicol. 2002 Aug;25(3):281-92 - PubMed
- Reprod Toxicol. 2004 Dec;19(2):163-7 - PubMed
- Chem Biol Interact. 2002 Jan 22;139(1):79-95 - PubMed
- J Cardiovasc Pharmacol. 2000 Aug;36(2):182-7 - PubMed
- Biochem Pharmacol. 1992 Aug 18;44(4):747-53 - PubMed
- Reprod Toxicol. 2007 Nov-Dec;24(3-4):365-70 - PubMed
- Andrologia. 2007 Oct;39(5):185-9 - PubMed
- Methods Enzymol. 1999;299:15-27 - PubMed
- Am J Ind Med. 1983;4(1-2):149-61 - PubMed
- Hum Exp Toxicol. 2008 Jan;27(1):49-54 - PubMed
- Free Radic Res. 2002 Nov;36(11):1209-18 - PubMed
- Hum Exp Toxicol. 2001 Dec;20(12):643-50 - PubMed
- Endocrinol Metab Clin North Am. 1998 Dec;27(4):927-43 - PubMed
- Toxicology. 2006 Jan 5;217(1):71-8 - PubMed
- Exp Biol Med (Maywood). 2004 Mar;229(3):264-9 - PubMed
- Chem Biol Interact. 2004 Dec 30;151(1):13-9 - PubMed
- Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2623-9 - PubMed
- Toxicology. 2006 May 1;222(1-2):60-70 - PubMed
- Indian J Exp Biol. 1980 Sep;18(9):1001-4 - PubMed
- Biochem Biophys Res Commun. 1997 Jul 18;236(2):407-12 - PubMed
- Br J Cancer Suppl. 1986;7:89-101 - PubMed
- Neurosci Lett. 2003 Oct 30;350(3):173-7 - PubMed
Publication Types